Table 4.
Therapy approach.
| I | Immunoglobulins | 1 cycle of 2 g/kg body weight given in 2 days |
| II | Cortisone | Methylprednisolone 20–30 mg/kg/day (maximum 1 g/day) for 3 days, then 1–2 mg/kg/d until day 7, then linear reduction over 2–3 weeks |
| III | Acetylsalicylic acid | 30–50 mg/kg/day until the patient has no fever for 48 h, then a low dose 3–5 mg/kg/day for 6 weeks |
| IV | Antibiotics | Piperacillin/tazobactam (preferred in cases of abdominal problems), cefotaxim (along with daptomycin), additional clindamycin in cases of signs of shock |
| Adjuvant therapy | Gastric protection | PPI 1–2 mg/day until cortisone is reduced |
| Thrombosis prophylaxis | Low-molecular heparin or continuous heparin | |
| Biologic drugs | IL-1 inhibitor (anakinra), or IL-6 inhibitor (tocilizumab), or TNF-α inhibitor (infliximab) |